+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Insomnia - Pipeline Review, H2 2019

  • ID: 4894274
  • Drug Pipelines
  • December 2019
  • Region: Global
  • 152 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Artelo Biosciences Inc
  • Cannabis Science Inc
  • Eisai Co Ltd
  • Evotec SE
  • Jazz Pharmaceuticals Plc
  • NeuroFix Therapeutics LLC
  • MORE
Insomnia - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Insomnia - Pipeline Review, H2 2019, provides an overview of the Insomnia (Central Nervous System) pipeline landscape.

Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches and distress in the stomach and intestines. Risk factors include age, mental health disorder, stress and shift working.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Insomnia - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Insomnia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Insomnia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Insomnia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 3, 12, 6, 7 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Insomnia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Insomnia (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Insomnia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Insomnia (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Insomnia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Insomnia (Central Nervous System)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Insomnia (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Insomnia (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Artelo Biosciences Inc
  • Cannabis Science Inc
  • Eisai Co Ltd
  • Evotec SE
  • Jazz Pharmaceuticals Plc
  • NeuroFix Therapeutics LLC
  • MORE
Introduction
Insomnia - Overview
Insomnia - Therapeutics Development
Insomnia - Therapeutics Assessment
Insomnia - Companies Involved in Therapeutics Development
Insomnia - Drug Profiles
Insomnia - Dormant Projects
Insomnia - Discontinued Products
Insomnia - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Insomnia, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Insomnia - Pipeline by Amherst Pharmaceuticals LLC, H2 2019
Insomnia - Pipeline by Artelo Biosciences Inc, H2 2019
Insomnia - Pipeline by Biohemp International Inc, H2 2019
Insomnia - Pipeline by Cannabis Science Inc, H2 2019
Insomnia - Pipeline by Cennerv Pharma (S) Pte Ltd, H2 2019
Insomnia - Pipeline by Ci Therapeutics, H2 2019
Insomnia - Pipeline by Cosmas Therapeutics Development Inc, H2 2019
Insomnia - Pipeline by Druggability Technologies Holdings Ltd, H2 2019
Insomnia - Pipeline by Eisai Co Ltd, H2 2019
Insomnia - Pipeline by EUSOL Biotech Co Ltd, H2 2019
Insomnia - Pipeline by Evotec SE, H2 2019
Insomnia - Pipeline by Grupo Ferrer Internacional SA, H2 2019
Insomnia - Pipeline by Idorsia Pharmaceutical Ltd, H2 2019
Insomnia - Pipeline by Imbrium Therapeutics LP, H2 2019
Insomnia - Pipeline by Intra-Cellular Therapies Inc, H2 2019
Insomnia - Pipeline by Jazz Pharmaceuticals Plc, H2 2019
Insomnia - Pipeline by Johnson & Johnson, H2 2019
Insomnia - Pipeline by Linnet BioPharmaceuticals Inc, H2 2019
Insomnia - Pipeline by NB Health Laboratory Co Ltd, H2 2019
Insomnia - Pipeline by Neurim Pharmaceuticals Ltd, H2 2019
Insomnia - Pipeline by NeuroFix Therapeutics LLC, H2 2019
Insomnia - Pipeline by Overseas Pharmaceuticals Ltd, H2 2019
Insomnia - Pipeline by Renascence Therapeutics Ltd, H2 2019
Insomnia - Pipeline by Reviva Pharmaceuticals Inc, H2 2019
Insomnia - Pipeline by Sage Therapeutics Inc, H2 2019
Insomnia - Pipeline by Shionogi & Co Ltd, H2 2019
Insomnia - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H2 2019
Insomnia - Pipeline by Tetranov International Inc, H2 2019
Insomnia - Pipeline by Tritech Biopharmaceuticals Co Ltd, H2 2019
Insomnia - Pipeline by Yangtze River Pharmaceutical Group, H2 2019
Insomnia - Pipeline by Zelda Therapeutics Pty Ltd, H2 2019
Insomnia - Dormant Projects, H2 2019
Insomnia - Dormant Projects, H2 2019 (Contd..1), H2 2019
Insomnia - Dormant Projects, H2 2019 (Contd..2), H2 2019
Insomnia - Discontinued Products, H2 2019

List of Figures
Number of Products under Development for Insomnia, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Stage and Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amherst Pharmaceuticals LLC
  • Artelo Biosciences Inc
  • Biohemp International Inc
  • Cannabis Science Inc
  • Cennerv Pharma (S) Pte Ltd
  • Ci Therapeutics
  • Cosmas Therapeutics Development Inc
  • Druggability Technologies Holdings Ltd
  • Eisai Co Ltd
  • EUSOL Biotech Co Ltd
  • Evotec SE
  • Grupo Ferrer Internacional SA
  • Idorsia Pharmaceutical Ltd
  • Imbrium Therapeutics LP
  • Intra-Cellular Therapies Inc
  • Jazz Pharmaceuticals Plc
  • Johnson & Johnson
  • Linnet BioPharmaceuticals Inc
  • NB Health Laboratory Co Ltd
  • Neurim Pharmaceuticals Ltd
  • NeuroFix Therapeutics LLC
  • Overseas Pharmaceuticals Ltd
  • Renascence Therapeutics Ltd
  • Reviva Pharmaceuticals Inc
  • Sage Therapeutics Inc
  • Shionogi & Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Tetranov International Inc
  • Tritech Biopharmaceuticals Co Ltd
  • Yangtze River Pharmaceutical Group
  • Zelda Therapeutics Pty Ltd
Note: Product cover images may vary from those shown
Adroll
adroll